277 results on '"Zeybek, Burak"'
Search Results
2. Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
3. Integrated mutational landscape analysis of uterine leiomyosarcomas
4. DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo
5. Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu
6. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma
7. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
8. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma
9. PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib
10. PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers
11. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitor
12. 17. Robotic procedures for management of apical compartment prolapse
13. 9. Laparoscopy/robotically assisted simple hysterectomy procedure
14. Immunotherapy in Cervical Cancer
15. Understanding the Legal Essentials of a Bowel Injury Lawsuit in Minimally Invasive Gynecologic Surgery
16. Novel antibody–drug conjugates: current and future roles in gynecologic oncology
17. Comparison of the Long-term Impact and Clinical Outcomes of Fewer Doses and Standard Doses of Human Papillomavirus Vaccine in the United States: A Database Study
18. Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence
19. Microarray gene expression analysis of uterosacral ligaments in uterine prolapse
20. Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies
21. Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
22. Pelvic Pain and Apical Prolapse Surgery: A Population-Based Retrospective Cohort Study
23. Infertility and the Presence of Insulin Resistance Are Associated With Increased Oxidative Stress in Young, Non-obese Turkish Women With Polycystic Ovary Syndrome
24. Learning Curve Analysis of Intracorporeal Cuff Suturing During Robotic Single-Site Total Hysterectomy
25. Effect of spaced training with a box trainer on the acquisition and retention of basic laparoscopic skills
26. Single-Site Robotic Total Hysterectomy: Standardization of Technique and Surgical Outcomes
27. The Impact of Varying Numbers of Quadrivalent Human Papillomavirus Vaccine Doses on Anogenital Warts in the United States: A Database Study
28. Alterations in Pre/Post Oxygenator Flows Due to Fibrin Deposition in the CardioHelp System—A Case Report
29. Overcoming the obstacles of visualization in robotically assisted abdominal cerclage using indocyanine green
30. Restless legs syndrome is related to obstructive sleep apnea symptoms during pregnancy
31. A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
32. Innovative Technique for Enclosed Morcellation Using a Surgical Glove
33. Recurrent brain tumor with hydrocephalus in pregnancy
34. Analysis of the learning curve for robotic hysterectomy for benign gynaecological disease
35. Randomized phase II trial of weekly ixabepilone with or without biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
36. In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma
37. Legal concerns and perceptions among women with gynecologic malignancies using prescribed medical cannabis: a single-institution, survey-based study
38. Financial toxicity in patients with gynecologic malignancies
39. Charlson Comorbidity Index as a predictor of postoperative complication in octogenarians and nonagenarians with stage I endometrioid endometrial cancer: a single-institution retrospective review
40. Abstract 911:In vitroandin vivoactivity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma
41. Prenatal diagnosis of infantile myofibromatosis of the lung: A case report and review of the literature
42. Polymorphisms in the activin A receptor type 2A gene affect the onset time and severity of preeclampsia in the Turkish population
43. High-output cardiac failure in a fetus with thanatophoric dysplasia associated with large placental chorioangioma: Case report
44. Novel mesothelin antibody-drug conjugates: current evidence and future role in the treatment of ovarian cancer
45. Financial toxicity in patients with gynecologic malignancies: a cross sectional study
46. Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study
47. Abstract 5341: Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma
48. Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent
49. Novel antibody–drug conjugates: current and future roles in gynecologic oncology
50. Sacituzumab govitecan: A promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.